J uxtarenal aortic aneurysms (JRA) account for approximately 15% of abdominal aortic aneurysms.
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Owing to the significant risk for open surgery, FEVAR was planned. The anatomy was suitable for FEVAR but the right common iliac artery (CIA) was dilated, necessitating the extension of the right iliac limb into the external iliac artery (EIA). The decision was made to proceed with coiling of the right internal iliac artery (IIA) one week prior to FEVAR. FEVAR was performed in July 2018, 3 months after CTA diagnosis as obtaining a factory customized aortic stent can take 2-3 months. FEVAR is performed in the hybrid or equipped with a flexible C-arm (Philips Allura Xper FD20, WA, USA). The operation was performed under general anesthesia via bilateral open common femoral artery (CFA) access with the patient under general anesthesia and on heparin therapy (1 bolus dose of 70 The fenestrated stent graft was then fully unsheathed. Then celiac artery was cannulated with a Terumo 0.035-inch wire over a Simmon1 catheter, which was then exchanged to Amplatz stiff wire followed by a 7F Flexor ® Ansel guiding sheath (Cook). BeGraft 8 mm × 27 mm covered stent was then deployed through the sheath and flared out. Another endograft (Cook ® Aortic 28 mm × 80 mm) introduced via the left CFA was deployed inferiorly as far as the aortic bifurcation and unsheathed. CIA endograft (Cook ® iliac limb 13 mm × 107 mm) was deployed ( Figure 3 ). The aortic body was balloon molded after each deployment. Final check angiography revealed stent in proper position without any endoleak. All devices and guide wires were removed. Both CFAs were closed primarily using 6/0 polypropylene sutures. The patient was extubated and transferred to the CCU in satisfactory condition. The patient received 48 hours of intravenous cefazolin post-operatively and was monitored clinically for any infection. He was discharged well on the fourth post-operative day. The computed tomography angiography at 1 month showed small type II endoleak at right posterolateral aspect of aortic bifurcation (Figure 4) . IU/kg). With the angiographic aid of a descending thoracic aortic pigtail catheter introduced via left femoral artery access, the fenestrated graft was introduced through the right CFA. The vertical position and rotational anatomy of the fenestrations were confirmed on angiography. The graft was then partially deployed. Using a larger 14F sheath via the left CFA which was free, right renal artery, left renal artery and SMA were sequentially cannulated with Terumo 0.035-inch wires over Cobra C2 catheters (Cook, Bloomington, IN, USA), which were then exchanged for Amplatz stiff wires followed by 7F Flexor ® Ansel guiding sheaths (Cook). BeGraft 6 mm × 22 mm, 6 mm × 22 mm and 8mm×37mm covered stents were then deployed through the sheaths and respectively flared out (Figure 2 ).
Discussion
Open surgery for juxtarenal aortic aneurysm, if compared with infrarenal aortic aneurysm, is characterized by more extensive mobilization of viscera to achieve adequate exposure of the abdominal aorta and by a period of renal ischemia, potentially increasing operative risk, especially the risk of postoperative renal dysfunction. This complex aortic pathology remains a challenge for suitable endovascular repair without compromising visceral perfusion. Even though the advances in stent-graft technology now permit aneurysm necks ≤ 10 mm to be treated by classical EVAR. However, in standard EVAR the complication rates climb rapidly with increasing numbers of adverse features in the proximal neck. , which were then exchanged to Amplatz stiff wires followed by 7F Flexor® Ansel guiding sheaths (Cook). BeGraft 6 mm × 22 mm, 6 mm × 22 mm and 8 mm × 37 mm covered stents were then deployed through the sheaths and respectively flared out.
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It is clear that a large number of patients are excluded from EVAR due to inadequate aneurysm neck length. 4 There are as yet no data extrapolating this to identify the proportion of patients eligible for FEVAR.
Custom design and manufacture of these grafts excludes their utility in the acute setting. Current time to manufacture is 6-8 weeks. ''Off-label'' surgeon-modified devices have been described, on-site modifications of commercially available aortic endografts.5 More complex procedures may increase operating time and rates of graft-related endoleak. Until an ''off-the-shelf'' device is created this remains the only option in emergencies where open repair is prohibited.
A recent study reported outcomes of FEVAR as a first line strategy for short neck, juxtarenal, and suprarenal aortic aneurysms in a large volume center, Technical success is 96.8%, thirty day mortality is 0.7% and freedom from reintervention rate for FEVAR at one and 3 years are 96.1% ± 1.4% and 90% ± 2.7% respectively.6 This is a consistent finding in EVAR. Interventions appear to occur within the first postoperative year and subsequently plateau. Close surveillance is essential to identify visceral vessel stenosis or pre-occlusion. Robust statistical comparison of FEVAR versus traditional open surgery would only be possible in a prospective randomized controlled trial. No such trial has been devised in the 10 years of evolution of FEVAR and it may never happen.
Conclusion
Fenestrated endovascular stent grafting is a feasible alternative for treatment of complex abdominal aortic aneurysms in high risk patients with a high technical success and low operative mortality and morbidity rates. 
